John Basgen to Diabetic Nephropathies
This is a "connection" page, showing publications John Basgen has written about Diabetic Nephropathies.
Connection Strength
0.589
-
DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity. J Clin Invest. 2021 05 17; 131(10).
Score: 0.164
-
Evaluation of glomerular lesions in diabetes mellitus. Kidney Int. 2000 Dec; 58(6):2592-3.
Score: 0.159
-
Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am J Nephrol. 2006; 26(5):430-6.
Score: 0.059
-
Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats. Am J Nephrol. 2004 Sep-Oct; 24(5):549-56.
Score: 0.052
-
An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int. 2002 Jun; 61(6):2058-66.
Score: 0.044
-
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int. 2002 Mar; 61(3):939-50.
Score: 0.043
-
Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int. 2001 Jun; 59(6):2104-13.
Score: 0.041
-
Diabetic glomerulopathy in the uninephrectomized rat resists amelioration following islet transplantation. Diabetologia. 1982 Oct; 23(4):347-53.
Score: 0.011
-
Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats. Diabetes. 1980 Jul; 29(7):509-15.
Score: 0.010
-
Estimation of mean glomerular volume in patients with insulin-dependent diabetes mellitus. Kidney Int. 1987 Dec; 32(6):930-2.
Score: 0.004